Since the early 2000s, high-throughput genomics technologies have demonstrated that breast cancer has five clinically relevant molecular subtypes defined by intrinsic gene expression patterns of the cancer [11–15]: Luminal A, Luminal B, Her2-enriched, basal-like, and normal breast-like cancer. This evidence concerns the gene ERBB2 and breast cancer.